@lukas_vaisnora Profile picture

Lukas Vaisnora, MD

@lukas_vaisnora

Similar User
Bashir Alaour photo

@BashirAlaour

Cardiovascular Research Cluster (CVRC) photo

@BernCVRC

Nick Tanatorn photo

@NicknameTanato1

Flavio Biccirè photo

@FBiccire

Anna Franzone photo

@franzone_anna

Raffaele Piccolo photo

@piccoloraf

Joanna Bartkowiak photo

@joan_bartc

pavelovertchouk photo

@pavelovertchouk

Taishi Okuno photo

@taishiokuno

Christoph Gräni photo

@chrisgraeni

Thomas Nestelberger photo

@thomas_nest

Andrea Zito photo

@AndreaZito66

Stefan Stortecky photo

@StefanStortecky

Thomas Pilgrim photo

@ThomPilgrim

K Spargias photo

@kspargias

Lukas Vaisnora, MD Reposted

Today on behalf of the investigators at TCT, I was honored to present the results of the Impella ECP pivotal trial. I extend my congratulations for this major milestone in the space of MCS to all my co investigators, research teams, and sponsor Abiomed. Small bore MCS is here!

Tweet Image 1
Tweet Image 2
Tweet Image 3
Tweet Image 4

Lukas Vaisnora, MD Reposted

When it comes to transfemoral access for TAVR it is all about diameter, calcification and tortuosity. In the Bern TAVI registry, the Hostile score proved useful in predicting non-puncture site vascular complications after TAVR. authors.elsevier.com/sd/article/S19…

Tweet Image 1

Lukas Vaisnora, MD Reposted

#TRACStrial (#TAVR without onsite surgery) has been presented during #LondonValves2023 as a possible solution for shorter waiting list in #TAVR, do you have this issue in your center?

Tweet Image 1

Lukas Vaisnora, MD Reposted

LEFT ATRIAL APPENDAGE OCCLUSION: pathophysiology, patient selection, procedural performance, treatment outcomes, adjunctive therapy, complications, and outcomes of LAAO for selected patients with non-valvular AF at risk for stroke. ow.ly/pgBX50MKHNX

Tweet Image 1

Lukas Vaisnora, MD Reposted

Retweet to join us in celebrating our Ally 🇱🇹#Lithuania on their State Restoration Day! 🤝 #WeAreNATO

Tweet Image 1

Lukas Vaisnora, MD Reposted

In the proof-of-concept OPTICA study, aspirin withdrawal directly after PCI for ACS without ST-segment elevation was not associated with apparent safety concerns given the absence of stent thrombosis and spontaneous myocardial infarction at six months. eurointervention.pcronline.com/article/single…

Tweet Image 1

Lukas Vaisnora, MD Reposted

Groundbreaking work on OHCA! In this #JACC piece, Drs. @AlessSpirito, @RaberLorenz, et al evaluate acute coronary artery occlusion in pts w/ #OHCA w/out ST elevation on #ECG. Their findings may surprise clinicians inside and outside #Cardiology. bit.ly/3jpFn2X @vlgmrc

Tweet Image 1

Lukas Vaisnora, MD Reposted

Left atrial appendage closure versus medical therapy: the APPLY study by Gloekler S, et al. #EIJBestOf #LAAC ow.ly/XkJc50KtWx4

Tweet Image 1

Lukas Vaisnora, MD Reposted

Bern OHCA registry results in JACC: #OHCA patients without ST-segment elevation, chest pain or shockable rhythm rather than hemodynamic status identifies patients with acute coronary occlusion (1/5 patients w occlusions). authors.elsevier.com/a/1gW1I2d9GHsl… authors.elsevier.com/a/1gW1I2d9GHsl…


Lukas Vaisnora, MD Reposted

Amulet IDE trial: Dual occlusive mechanism of Amulet was assoc. w/ ⬇️ occurrence of peridevice leak ≥3mm vs single occlusive mechanism of Watchman 2.5. Peridevice leak ≥3mm was assoc. w/ a significantly ⬆️ 18-month risk of adverse outcomes. bit.ly/3TNZggm #JACCINT

Tweet Image 1

Lukas Vaisnora, MD Reposted

Today's JACC: Temporal trends in TAVR vs SAVR in 142,953 pts between 2015 and 2021 from >250 US hospitals. Increasing TAVR over time in all age groups. TAVR dominant in ≥65yo pts, ~50% in <65yo pts. We need more bicuspid and ≥10-year data. @HarryDauerman

Tweet Image 1

Lukas Vaisnora, MD Reposted

Happy to announce the opening of one coronary intervention fellow position at Cardiocentro Ticino Institute for 2023. Apply via marco.valgimigli@eoc.ch


Lukas Vaisnora, MD Reposted

Fantastic overview on how to image the tricuspid valve - extremely useful for interventional cardiologists as well! @chrismeduri @GilbertTangMD @nickaram #TreatTR

Thanks @iamritu for highlighting—#echofirst Imaging the #tricuspidvalve takes practice. @escardio #ESCCongress #ESC2019

Tweet Image 1
Tweet Image 2
Tweet Image 3
Tweet Image 4


Lukas Vaisnora, MD Reposted

One in 3 aortic stenosis patients with an LVEF <50% experienced LVEF improvement of 10% or more within 30 days after TAVR. ja.ma/3BmjV5u

Tweet Image 1

Lukas Vaisnora, MD Reposted

Differentiating VT Form SVT on #ECG can be challenging! We developed a user friendly algorithm based on clinical info and 2 leads (II,aVR). In a clinical validation residents and fellows are as proficient as #EPeeps @JACCJournals tinyurl.com/44bfs5kx

Tweet Image 1

Lukas Vaisnora, MD Reposted

This study investigated the changes in collateral function after PCI of chronic total occlusions and found a significant regression of collaterals at 3 months that was independent of the recanalization technique. #CTO ow.ly/bJpu50JS4qr

Tweet Image 1

Lukas Vaisnora, MD Reposted

What are the outcomes of unconscious vs. conscious out-of-hospital cardiac arrest patients undergoing #PCI? Unconscious patients had ⬆️ death, ⬆️ stent #thrombosis and ⬆️ bleeding. bit.ly/3aqtTYG #JACCINT #cvACS #CardioTwitter @AlessSpirito @vlgmrc

Tweet Image 1

Lukas Vaisnora, MD Reposted

Non-cardiac surgery after TAVI: What are the concerns? Check out our latest publication- Risk and Timing of Noncardiac Surgery After Transcatheter Aortic Valve Implantation ja.ma/3uwQklw via @JAMANetworkOpen part of @JAMANetwork


Lukas Vaisnora, MD Reposted

Rhythm monitoring after TAVI by use of an implantable cardiac monitor revealed new arrhythmias, mainly atrial fibrillation, in almost one third of patients within 12 months. @FabienPraz @joan_bartc @StefanStortecky frontiersin.org/article/10.338…

Tweet Image 1

Lukas Vaisnora, MD Reposted

So happy!!! Thank u all for ur love and support! Now is holiday time :) http://t.co/C9AsOdt4

Tweet Image 1

Loading...

Something went wrong.


Something went wrong.